INBS Partnership Signals Expansion Into Rapidly Growing Wearable Health Tech Sector

Collaboration Positions INBS to Capture New Revenue in the $168 Billion Wearable Devices Market

Intelligent Bio Solutions Inc. (NASDAQ:INBS) has entered into a strategic alliance with Vlepis Pty Ltd, aiming to harness their combined strengths in non-invasive testing and advanced wearable patch technologies. The partnership comes as the global wearable medical devices market is forecasted to nearly quadruple from $42.7 billion in 2024 to $168.3 billion by 2030, representing annual growth of over 25%.

Targeting Consumer Health Monitoring as Market Demand Accelerates

The new agreement expands INBS’s potential far beyond its commercial screening roots, positioning the company to break into the fast-evolving consumer health sector. According to market research, the wider consumer healthcare market is currently valued at $383.7 billion and is expected to reach $548.7 billion by 2030. With this move, INBS is tapping into surging demand for accessible, connected, and non-invasive health monitoring solutions for both businesses and individual consumers.

Combining Innovative Wearables with Established Drug Screening Solutions

INBS, known for its Intelligent Fingerprinting Drug Testing Solution and the recently launched SMARTOX SmarTest Patch, sees Vlepis’s suite of sensor-enabled wearable patches as the perfect complement to its own products. The partnership is designed to advance R&D collaboration, expand distribution reach, and integrate Vlepis’s cloud-connected software with INBS’s existing ecosystem.

Here’s a look at the relevant market statistics supporting this strategy:

Potential for Fast Commercialization Leveraging Global Distribution

By joining forces, INBS and Vlepis intend to leverage their distributor relationships and regulatory know-how to bring new wearable products to international markets quickly. INBS’s footprint spans over 24 countries, offering an immediate avenue for commercialization. The companies plan to address high-growth areas such as remote health monitoring, aged-care, community support, and direct-to-consumer telehealth platforms.

Why This Partnership Matters for INBS’s Future

This collaboration isn’t just about adding another product—it’s a strategic push for INBS into a segment where integrated health technology, convenience, and remote care are rapidly becoming essential. As connected technologies increasingly drive operational insights and patient engagement, INBS’s focus on non-invasive, easy-to-use solutions positions it for strong future relevance.

Key Takeaway: New Pathways for Growth in Health Tech

INBS’s strategic alliance with Vlepis may open the door to broader markets and deeper consumer penetration. Investors and industry observers should watch how the partnership unfolds and whether INBS’s established commercial base accelerates adoption of next-generation wearable health devices.

Contact Information:

If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.

About the Publisher - Marketchameleon.com:

Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.

NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.

The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.

Disclosure: This article was generated with the assistance of AI